A former adviser to President Donald Trump during the COVID-19 pandemic said the United States is equipped to handle an Ebola outbreak [1, 2].
The statement comes amid concerns regarding the current state of U.S. public health leadership. The lack of confirmed heads at the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA) has raised questions about the government's ability to coordinate a rapid response to a high-consequence pathogen.
Speaking Sunday, the former adviser said that existing public-health infrastructure and resources remain sufficient to manage the threat [1, 2]. The adviser said that the operational capacity of these agencies does not depend solely on the presence of a confirmed director.
"The U.S. right now does not have a confirmed head of the CDC, it does not have a confirmed head of the FDA, but we are equipped to handle an Ebola outbreak," the former adviser said [1].
This assertion of readiness contrasts with other reports regarding the U.S. global health posture. Some sources suggest the current response is hampered by the previous dismantling of global-health programs during the Trump administration [3]. These reports indicate that the withdrawal from international health initiatives has weakened the overall capacity of the U.S. to respond to major outbreaks.
The tension between these viewpoints highlights a broader debate over whether institutional bureaucracy and established protocols can sustain a crisis response in the absence of top-level political appointments. While the former adviser maintains that the machinery of the CDC and FDA is functional, critics argue that the loss of strategic leadership and funding creates systemic vulnerabilities.
“The U.S. right now does not have a confirmed head of the CDC, it does not have a confirmed head of the FDA, but we are equipped to handle an Ebola outbreak.”
The conflict between the adviser's claims and reports of dismantled health programs suggests a divide in how the U.S. evaluates its pandemic readiness. If the response is indeed hobbled by previous policy shifts and current leadership vacancies, the U.S. may face challenges in coordinating with international partners and deploying resources effectively during a surge.
